News and Updates
(click the images for more info)
FDA Approves 1st Drug Treatment for Sickle Cell Disease in 20 years.
Endari is indicated to reduce the acute complications of sickle cell disease in adult and pediatric patients 5 years of age and older. The most common adverse reactions occurring in greater than 10 percent of patients receiving Endari in clinical studies were constipation, nausea, headache, abdominal pain, cough, pain in the extremities, back pain, and chest pain. Endari should only be taken under the direction of a physician. Endari has received Orphan Drug designation in the U.S. and Orphan Medicinal Product designation in the EU.
"Camp Gibbous", is the WINNER of the 2017 “Helping U Help Your Community" Grant
SCDFC Thanks Wilson High School's Young Black Scholars.
Tragic passing of